Therapeutic Asset Ratings

Ribociclib

rp903

vx-970

Zimberelimab

NC 410

Immunoglobulin G1 [188,412-bis[4-(azidomethyl)-L-phenylalanine]], anti-(human folate receptor ?) (human-Mus musculus monoclonal SP8166 ?1-chain), disulfide with human-Mus musculus monoclonal SP8166 ?-chain, dimer, click reaction product with 3-[[[[4-[[N-[4-(11,12-didehydrodibenz[b,f]azocin-5(6H)-yl)-1,4-dioxobutyl]-L-valyl-N5-(aminocarbonyl)-L-ornithyl]amino]phenyl]methoxy]carbonyl]amino]-N,?,?-trimethyl-L-phenylalanyl-N-[(1S,2E)-3-carboxy-1-(1-methylethyl)-2-buten-1-yl]-N,3-dimethyl-L-valinamide (1:4)

[177lu]lu-evs459

[68ga]ga-evs459

ab598

Abbv-901

Amivantamab-Vmjw

Amt-151

Anti-Cd70-Car-T Cells

Arog4-01

asp1893

Atv-1601

Atx-295

Autologous, Engineered T Cells Targeting Tp53 R175H

Autologous Genetically Modified Mage-A4ᶜ¹º³²T Cells

b7-h3cart

Balstilimab

Bdc-3042

bg-68501

Bgb-43395

bl0175